Fanconi syndrome historical perspective: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Fanconi syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{Reflis...")
 
No edit summary
 
(6 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Fanconi syndrome}}
{{Fanconi syndrome}}
{{CMG}}; {{AE}} {{VE}}


Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
==Overview==
Fanconi syndrome is nominated after the name of professor [[Guido Fanconi]], who first explained the detailed characteristics of the disease in 1931<ref name=":0">Fanconi G. Die nicht diabetischen Glykosurien und Hyperglykaemien des aelteren Kindes. Jahrbuch fuer Kinderheilkunde 1931; 133: 257–300</ref>. He investigated and proposed the possible links between dwarfing and hypophosphataemic [[rickets]] to renal [[glycosuria]] in children suffering from the disease<ref>Fanconi G. Der nephrotisch-glykosurische Zwergwuchs mit hypophosphataemischer Rachitis. Deutsche Medizinische Wochenschrift 1936; 62: 1169–1171</ref><ref name=":0" />. 
 
==Historical Perspective==
 
===Discovery===
* Simultaneous rickets and [[albuminuria]] due to kidney disease were first described in 1881 referred ‘disorder of adolescence', but the precise mechanism remained unknown<ref>Lucas RC. On a form of late rickets associated with albuminuria, rickets of adolescence. Lancet 1883: 993–994</ref>.
 
* Fanconi syndrome was first explained as a renal proximal tubule defect with details by [[Guido Fanconi]], a Swiss pediatrician, in 1931<ref name=":0" />.
* Besides Dr. Fanconi, the clinical characteristics of the disease were further studied by Debre and De Toni, that’s why the disease is also called [[Fanconi syndrome|Debre-De Toni-Fanconi syndrome]]<ref>De Toni G. Remarks on the relationship between renal rickets (renal dwarfism) and renal diabetes. Acta Pediatr 1933; 16: 479–484</ref><ref>Debre R, Marie J, Cleret F et al. Rachitisme tardif coexistant avec une Nephrite chronique et une Glycosurie. Archive de Medicine des Enfants 1934; 37: 597–606</ref>.
* In 1949 Professor Fanconi and his assistant Dr. Horst Bickel described a rare type of [[Glycogen storage disease]] characterized by [[GLUT2]] glucose transporter mutations which leads to liver, pancreas and [[kidney failure]]. The disease was further named [[Glycogen storage disease type XI|Fanconi-Bickel syndrome]], Although the renal involvement of this syndrome is mostly the renal Fanconi syndrome, these two syndromes are separate diseases<ref>Fanconi G, Bickel H (1949) Die chronische Aminoacidurie (AminosaÈ urediabetes oder nephrotisch-glukosurischer Zwerg wuchs) bei der Glykogenose und der Cystinkrankheit. Helv Paediatr Acta 4:359±396</ref>.
* Later on, the syndrome clinical characteristics were studied by many other scientists. As the Fanconi syndrome can result from many genetic disorders with various etiologies, drugs and substances effect on the kidneys, and also is one of the characteristics included in many complicated syndromes, the details of [[pathophysiology]] and [[genetic]] perspective of the disease is becoming more evident gradually from 40s decade<ref name="pmid25492894">{{cite journal| author=Klootwijk ED, Reichold M, Unwin RJ, Kleta R, Warth R, Bockenhauer D| title=Renal Fanconi syndrome: taking a proximal look at the nephron. | journal=Nephrol Dial Transplant | year= 2015 | volume= 30 | issue= 9 | pages= 1456-60 | pmid=25492894 | doi=10.1093/ndt/gfu377 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25492894  }}</ref>. 
* Even now in 2017, there are novel mutations and genetic loci discussed leading to the disease<ref name="pmid29654216">{{cite journal| author=Reichold M, Klootwijk ED, Reinders J, Otto EA, Milani M, Broeker C et al.| title=Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure. | journal=J Am Soc Nephrol | year= 2018 | volume=  | issue=  | pages=  | pmid=29654216 | doi=10.1681/ASN.2017111179 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29654216  }}</ref>.
 
==Landmark Events in the Development of Treatment Strategies==
** in 1950s, Mianstay treatment approach to the disease(replacement therapy) was first discussed and is still remains as the main therapeutic approach<ref name="pmid13271480">{{cite journal| author=SAVILLE PD, NASSIM R, STEVENSON FH, MULLIGAN L, CAREY M| title=The Fanconi syndrome; metabolic studies on treatment. | journal=J Bone Joint Surg Br | year= 1955 | volume= 37-B | issue= 4 | pages= 529-39 | pmid=13271480 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13271480  }}</ref>.
** Specific therapies modifying the underlying diseases continued to be introduced with the progression of disease comprehension. 


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
{{WH}}
[[Category:Organ disorders]]
{{WS}}
[[Category:Kidney diseases]]
[[Category: (name of the system)]]
[[Category:Disease]]

Latest revision as of 16:20, 21 July 2018

Fanconi syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fanconi syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study Of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fanconi syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fanconi syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fanconi syndrome historical perspective

CDC on Fanconi syndrome historical perspective

Fanconi syndrome historical perspective in the news

Blogs on Fanconi syndrome historical perspective

Directions to Hospitals Treating Fanconi syndrome

Risk calculators and risk factors for Fanconi syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vahid Eidkhani, M.D.

Overview

Fanconi syndrome is nominated after the name of professor Guido Fanconi, who first explained the detailed characteristics of the disease in 1931[1]. He investigated and proposed the possible links between dwarfing and hypophosphataemic rickets to renal glycosuria in children suffering from the disease[2][1]

Historical Perspective

Discovery

  • Simultaneous rickets and albuminuria due to kidney disease were first described in 1881 referred ‘disorder of adolescence', but the precise mechanism remained unknown[3].
  • Fanconi syndrome was first explained as a renal proximal tubule defect with details by Guido Fanconi, a Swiss pediatrician, in 1931[1].
  • Besides Dr. Fanconi, the clinical characteristics of the disease were further studied by Debre and De Toni, that’s why the disease is also called Debre-De Toni-Fanconi syndrome[4][5].
  • In 1949 Professor Fanconi and his assistant Dr. Horst Bickel described a rare type of Glycogen storage disease characterized by GLUT2 glucose transporter mutations which leads to liver, pancreas and kidney failure. The disease was further named Fanconi-Bickel syndrome, Although the renal involvement of this syndrome is mostly the renal Fanconi syndrome, these two syndromes are separate diseases[6].
  • Later on, the syndrome clinical characteristics were studied by many other scientists. As the Fanconi syndrome can result from many genetic disorders with various etiologies, drugs and substances effect on the kidneys, and also is one of the characteristics included in many complicated syndromes, the details of pathophysiology and genetic perspective of the disease is becoming more evident gradually from 40s decade[7]
  • Even now in 2017, there are novel mutations and genetic loci discussed leading to the disease[8].

Landmark Events in the Development of Treatment Strategies

    • in 1950s, Mianstay treatment approach to the disease(replacement therapy) was first discussed and is still remains as the main therapeutic approach[9].
    • Specific therapies modifying the underlying diseases continued to be introduced with the progression of disease comprehension. 

References

  1. 1.0 1.1 1.2 Fanconi G. Die nicht diabetischen Glykosurien und Hyperglykaemien des aelteren Kindes. Jahrbuch fuer Kinderheilkunde 1931; 133: 257–300
  2. Fanconi G. Der nephrotisch-glykosurische Zwergwuchs mit hypophosphataemischer Rachitis. Deutsche Medizinische Wochenschrift 1936; 62: 1169–1171
  3. Lucas RC. On a form of late rickets associated with albuminuria, rickets of adolescence. Lancet 1883: 993–994
  4. De Toni G. Remarks on the relationship between renal rickets (renal dwarfism) and renal diabetes. Acta Pediatr 1933; 16: 479–484
  5. Debre R, Marie J, Cleret F et al. Rachitisme tardif coexistant avec une Nephrite chronique et une Glycosurie. Archive de Medicine des Enfants 1934; 37: 597–606
  6. Fanconi G, Bickel H (1949) Die chronische Aminoacidurie (AminosaÈ urediabetes oder nephrotisch-glukosurischer Zwerg wuchs) bei der Glykogenose und der Cystinkrankheit. Helv Paediatr Acta 4:359±396
  7. Klootwijk ED, Reichold M, Unwin RJ, Kleta R, Warth R, Bockenhauer D (2015). "Renal Fanconi syndrome: taking a proximal look at the nephron". Nephrol Dial Transplant. 30 (9): 1456–60. doi:10.1093/ndt/gfu377. PMID 25492894.
  8. Reichold M, Klootwijk ED, Reinders J, Otto EA, Milani M, Broeker C; et al. (2018). "Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure". J Am Soc Nephrol. doi:10.1681/ASN.2017111179. PMID 29654216.
  9. SAVILLE PD, NASSIM R, STEVENSON FH, MULLIGAN L, CAREY M (1955). "The Fanconi syndrome; metabolic studies on treatment". J Bone Joint Surg Br. 37-B (4): 529–39. PMID 13271480.

Template:WH Template:WS